Across TCGA pan-cancer cohorts, RPSAP33 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPSAP33’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RPSAP33 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP33 is over-expressed in tumor, although a few such as KIRC and UCEC show the opposite, repressed pattern.

THCA, KIRC, and UCEC are the cancer types where RPSAP33 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP33 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	All	+0.063	<.001	9	view →
KIRC	All	IV	−0.030	.012	6	view →
UCEC	All	II,III,IV	−0.158	.022	2	view →
LIHC	All	II,III,IV	+0.012	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RPSAP33 RNA expression & survival · all RPSAP33 data types